Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale

Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2015-01, Vol.21 (1), p.50-54
Hauptverfasser: Martínez-Martín, Pablo, Rodríguez-Blázquez, Carmen, Mario Alvarez, Arakaki, Tomoko, Arillo, Víctor Campos, Chaná, Pedro, Fernández, William, Garretto, Nélida, Martínez-Castrillo, Juan Carlos, Rodríguez-Violante, Mayela, Serrano-Dueñas, Marcos, Ballesteros, Diego, Rojo-Abuin, Jose Manuel, Chaudhuri, Kallol Ray, Merello, Marcelo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 54
container_issue 1
container_start_page 50
container_title Parkinsonism & related disorders
container_volume 21
creator Martínez-Martín, Pablo
Rodríguez-Blázquez, Carmen
Mario Alvarez
Arakaki, Tomoko
Arillo, Víctor Campos
Chaná, Pedro
Fernández, William
Garretto, Nélida
Martínez-Castrillo, Juan Carlos
Rodríguez-Violante, Mayela
Serrano-Dueñas, Marcos
Ballesteros, Diego
Rojo-Abuin, Jose Manuel
Chaudhuri, Kallol Ray
Merello, Marcelo
description Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.
doi_str_mv 10.1016/j.parkreldis.2014.10.026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668271579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1353802014004118</els_id><sourcerecordid>1668271579</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxSMEoqXwFVBucMl2_DfOBQnaQiu1KmLbs-XYY-Rt1lnsbKX99jjaBSpOPXnkee_N6KepqprAggCRp6vFxqSHhIMLeUGB8PK9ACpfVMdEtawRhMqXpWaCNQooHFVvcl4BQCuAva6OqOBScpDH1d33EhRiHuOHXJc0NBnrjI-YwrSrh1IMuTbR1Tfny-Y-Bh_Q1U895wfPDzOF-LNeWjPg2-qVN0PGd4f3pLr_enF3dtlc3367Ovt83diy4NRQtD0oZphyoqcOeE866EB4KVouvOu5B9kp1cmWedpZLzw3gnLGwTkgLTupPu5zN2n8tcU86XXIFofBRBy3WRMpFW2JaLtnSFnXzeJZqvZSm8acE3q9SWFt0k4T0DN-vdL_8OsZ_9wp-Iv1_WHKtl-j-2v8w7sIvuwFBSs-Bkw624DRogsJ7aTdGJ4z5dN_IXYIMRTyD7jDvBq3KRbsmuhMNejlfAbzFRAOwAlR7Dd0mK6v</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1639982719</pqid></control><display><type>article</type><title>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Martínez-Martín, Pablo ; Rodríguez-Blázquez, Carmen ; Mario Alvarez ; Arakaki, Tomoko ; Arillo, Víctor Campos ; Chaná, Pedro ; Fernández, William ; Garretto, Nélida ; Martínez-Castrillo, Juan Carlos ; Rodríguez-Violante, Mayela ; Serrano-Dueñas, Marcos ; Ballesteros, Diego ; Rojo-Abuin, Jose Manuel ; Chaudhuri, Kallol Ray ; Merello, Marcelo</creator><creatorcontrib>Martínez-Martín, Pablo ; Rodríguez-Blázquez, Carmen ; Mario Alvarez ; Arakaki, Tomoko ; Arillo, Víctor Campos ; Chaná, Pedro ; Fernández, William ; Garretto, Nélida ; Martínez-Castrillo, Juan Carlos ; Rodríguez-Violante, Mayela ; Serrano-Dueñas, Marcos ; Ballesteros, Diego ; Rojo-Abuin, Jose Manuel ; Chaudhuri, Kallol Ray ; Merello, Marcelo</creatorcontrib><description>Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2014.10.026</identifier><identifier>PMID: 25466406</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Assessment ; Cross-Sectional Studies ; Disability Evaluation ; Female ; Humans ; International Cooperation ; Male ; MDS-UPDRS ; Middle Aged ; Neurology ; Observation ; Parkinson Disease - diagnosis ; Parkinson Disease - physiopathology ; Parkinson's disease ; Severity ; Severity of Illness Index ; Staging ; Young Adult</subject><ispartof>Parkinsonism &amp; related disorders, 2015-01, Vol.21 (1), p.50-54</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</citedby><cites>FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.parkreldis.2014.10.026$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25466406$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martínez-Martín, Pablo</creatorcontrib><creatorcontrib>Rodríguez-Blázquez, Carmen</creatorcontrib><creatorcontrib>Mario Alvarez</creatorcontrib><creatorcontrib>Arakaki, Tomoko</creatorcontrib><creatorcontrib>Arillo, Víctor Campos</creatorcontrib><creatorcontrib>Chaná, Pedro</creatorcontrib><creatorcontrib>Fernández, William</creatorcontrib><creatorcontrib>Garretto, Nélida</creatorcontrib><creatorcontrib>Martínez-Castrillo, Juan Carlos</creatorcontrib><creatorcontrib>Rodríguez-Violante, Mayela</creatorcontrib><creatorcontrib>Serrano-Dueñas, Marcos</creatorcontrib><creatorcontrib>Ballesteros, Diego</creatorcontrib><creatorcontrib>Rojo-Abuin, Jose Manuel</creatorcontrib><creatorcontrib>Chaudhuri, Kallol Ray</creatorcontrib><creatorcontrib>Merello, Marcelo</creatorcontrib><title>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</title><title>Parkinsonism &amp; related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Assessment</subject><subject>Cross-Sectional Studies</subject><subject>Disability Evaluation</subject><subject>Female</subject><subject>Humans</subject><subject>International Cooperation</subject><subject>Male</subject><subject>MDS-UPDRS</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Observation</subject><subject>Parkinson Disease - diagnosis</subject><subject>Parkinson Disease - physiopathology</subject><subject>Parkinson's disease</subject><subject>Severity</subject><subject>Severity of Illness Index</subject><subject>Staging</subject><subject>Young Adult</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxSMEoqXwFVBucMl2_DfOBQnaQiu1KmLbs-XYY-Rt1lnsbKX99jjaBSpOPXnkee_N6KepqprAggCRp6vFxqSHhIMLeUGB8PK9ACpfVMdEtawRhMqXpWaCNQooHFVvcl4BQCuAva6OqOBScpDH1d33EhRiHuOHXJc0NBnrjI-YwrSrh1IMuTbR1Tfny-Y-Bh_Q1U895wfPDzOF-LNeWjPg2-qVN0PGd4f3pLr_enF3dtlc3367Ovt83diy4NRQtD0oZphyoqcOeE866EB4KVouvOu5B9kp1cmWedpZLzw3gnLGwTkgLTupPu5zN2n8tcU86XXIFofBRBy3WRMpFW2JaLtnSFnXzeJZqvZSm8acE3q9SWFt0k4T0DN-vdL_8OsZ_9wp-Iv1_WHKtl-j-2v8w7sIvuwFBSs-Bkw624DRogsJ7aTdGJ4z5dN_IXYIMRTyD7jDvBq3KRbsmuhMNejlfAbzFRAOwAlR7Dd0mK6v</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Martínez-Martín, Pablo</creator><creator>Rodríguez-Blázquez, Carmen</creator><creator>Mario Alvarez</creator><creator>Arakaki, Tomoko</creator><creator>Arillo, Víctor Campos</creator><creator>Chaná, Pedro</creator><creator>Fernández, William</creator><creator>Garretto, Nélida</creator><creator>Martínez-Castrillo, Juan Carlos</creator><creator>Rodríguez-Violante, Mayela</creator><creator>Serrano-Dueñas, Marcos</creator><creator>Ballesteros, Diego</creator><creator>Rojo-Abuin, Jose Manuel</creator><creator>Chaudhuri, Kallol Ray</creator><creator>Merello, Marcelo</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20150101</creationdate><title>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</title><author>Martínez-Martín, Pablo ; Rodríguez-Blázquez, Carmen ; Mario Alvarez ; Arakaki, Tomoko ; Arillo, Víctor Campos ; Chaná, Pedro ; Fernández, William ; Garretto, Nélida ; Martínez-Castrillo, Juan Carlos ; Rodríguez-Violante, Mayela ; Serrano-Dueñas, Marcos ; Ballesteros, Diego ; Rojo-Abuin, Jose Manuel ; Chaudhuri, Kallol Ray ; Merello, Marcelo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-2ecb083a38d5b2d04b190905f65745fdb4f069889673f29cf5f4a524340dd0173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Assessment</topic><topic>Cross-Sectional Studies</topic><topic>Disability Evaluation</topic><topic>Female</topic><topic>Humans</topic><topic>International Cooperation</topic><topic>Male</topic><topic>MDS-UPDRS</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Observation</topic><topic>Parkinson Disease - diagnosis</topic><topic>Parkinson Disease - physiopathology</topic><topic>Parkinson's disease</topic><topic>Severity</topic><topic>Severity of Illness Index</topic><topic>Staging</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez-Martín, Pablo</creatorcontrib><creatorcontrib>Rodríguez-Blázquez, Carmen</creatorcontrib><creatorcontrib>Mario Alvarez</creatorcontrib><creatorcontrib>Arakaki, Tomoko</creatorcontrib><creatorcontrib>Arillo, Víctor Campos</creatorcontrib><creatorcontrib>Chaná, Pedro</creatorcontrib><creatorcontrib>Fernández, William</creatorcontrib><creatorcontrib>Garretto, Nélida</creatorcontrib><creatorcontrib>Martínez-Castrillo, Juan Carlos</creatorcontrib><creatorcontrib>Rodríguez-Violante, Mayela</creatorcontrib><creatorcontrib>Serrano-Dueñas, Marcos</creatorcontrib><creatorcontrib>Ballesteros, Diego</creatorcontrib><creatorcontrib>Rojo-Abuin, Jose Manuel</creatorcontrib><creatorcontrib>Chaudhuri, Kallol Ray</creatorcontrib><creatorcontrib>Merello, Marcelo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Parkinsonism &amp; related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez-Martín, Pablo</au><au>Rodríguez-Blázquez, Carmen</au><au>Mario Alvarez</au><au>Arakaki, Tomoko</au><au>Arillo, Víctor Campos</au><au>Chaná, Pedro</au><au>Fernández, William</au><au>Garretto, Nélida</au><au>Martínez-Castrillo, Juan Carlos</au><au>Rodríguez-Violante, Mayela</au><au>Serrano-Dueñas, Marcos</au><au>Ballesteros, Diego</au><au>Rojo-Abuin, Jose Manuel</au><au>Chaudhuri, Kallol Ray</au><au>Merello, Marcelo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale</atitle><jtitle>Parkinsonism &amp; related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>21</volume><issue>1</issue><spage>50</spage><epage>54</epage><pages>50-54</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Abstract Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25466406</pmid><doi>10.1016/j.parkreldis.2014.10.026</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1353-8020
ispartof Parkinsonism & related disorders, 2015-01, Vol.21 (1), p.50-54
issn 1353-8020
1873-5126
language eng
recordid cdi_proquest_miscellaneous_1668271579
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adolescent
Adult
Aged
Aged, 80 and over
Assessment
Cross-Sectional Studies
Disability Evaluation
Female
Humans
International Cooperation
Male
MDS-UPDRS
Middle Aged
Neurology
Observation
Parkinson Disease - diagnosis
Parkinson Disease - physiopathology
Parkinson's disease
Severity
Severity of Illness Index
Staging
Young Adult
title Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parkinson's%20disease%20severity%20levels%20and%20MDS-Unified%20Parkinson's%20Disease%20Rating%20Scale&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Mart%C3%ADnez-Mart%C3%ADn,%20Pablo&rft.date=2015-01-01&rft.volume=21&rft.issue=1&rft.spage=50&rft.epage=54&rft.pages=50-54&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2014.10.026&rft_dat=%3Cproquest_cross%3E1668271579%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1639982719&rft_id=info:pmid/25466406&rft_els_id=1_s2_0_S1353802014004118&rfr_iscdi=true